| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.5B | $6.5B | $6.8B | $6.2B | $5.4B | $4.7B | $4.7B | $4.2B |
| Cost of Revenue | $4.3B | $4.7B | $4.8B | $4.7B | $4.1B | $3.5B | $3.6B | $3.3B |
| Gross Profit | $0.5B | $1.9B | $2.0B | $1.4B | $1.3B | $1.3B | $1.2B | $1.0B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $0.4B | $0.4B | $0.4B | $0.4B | $0.4B | $0.3B | $0.3B | $0.3B |
| Operating Income | $1.4B | $2.7B | $1.6B | $1.2B | $1.0B | $1.0B | $0.9B | $0.7B |
| Net Income | $0.3B | $2.0B | $1.2B | $0.9B | $0.7B | $0.7B | $0.6B | $0.5B |
| EPS (Basic) | $18.81 | $32.50 | $18.88 | $13.91 | $11.26 | $11.56 | $9.77 | $7.46 |
| EPS (Diluted) | $18.77 | $32.41 | $18.82 | $13.87 | $11.22 | $11.54 | $9.74 | $7.43 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $18.7B | $18.2B | $15.1B | $15.0B | $14.4B | $10.6B | $10.1B | $9.6B |
| Current Assets | $3.2B | $2.5B | $3.9B | $2.9B | $2.0B | $1.7B | $1.4B | $1.4B |
| Cash & Equivalents | $0.1B | $0.7B | $1.3B | $0.4B | $0.3B | $0.2B | $0.0B | $0.0B |
| Total Liabilities | $8.7B | $8.7B | $7.1B | $7.8B | $7.9B | $4.7B | $4.8B | $4.6B |
| Current Liabilities | $0.9B | $1.0B | $1.2B | $1.4B | $0.8B | $0.5B | $0.8B | $0.8B |
| Stockholders' Equity | $10.0B | $9.5B | $8.0B | $7.2B | $6.5B | $5.9B | $5.4B | $4.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.8B | $1.5B | $1.5B | $1.0B | $1.1B | $1.1B | $1.0B | $0.7B |
| Investing Cash Flow | $-1.6B | $-2.4B | $0.5B | $-0.5B | $-3.5B | $-0.4B | $-0.4B | $-1.9B |
| Capital Expenditures | $0.8B | $0.9B | $0.7B | $0.5B | $0.4B | $0.4B | $0.4B | $0.4B |
| Financing Cash Flow | $-0.8B | $0.4B | $-1.1B | $-0.4B | $2.3B | $-0.4B | $-0.6B | $-0.2B |